Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-type calcium channels (Cav3) are a subfamily of voltage-gated calcium channels characterized by their low threshold for activation and rapid inactivation. They play crucial roles in regulating electrical excitability and rhythmic firing in various cell types, including neurons and cardiac muscle cells. The family consists of three main isoforms: Cav3.1 (CACNA1G), Cav3.2 (CACNA1H), and Cav3.3 (CACNA1I). Dysfunction or mutations are linked with absence epilepsy, neuropathic pain and idiopathic epilepsy. They are targets for drug development especially for neurological disorders.
Blockage or modulation of calcium ion flow through the channel
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-type Calcium Channel Cav3 (Cav3).